Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The

dc.contributor.author	López López, Rafael
dc.date.accessioned	2017-06-07T07:12:02Z
dc.date.available	2017-06-07T07:12:02Z
dc.date.issued	2015
dc.identifier.issn	095-9804
dc.identifier.uri	http://hdl.handle.net/20.500.11940/3737
dc.language.iso	eng
dc.title	Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The
dc.type	Publicación de congreso
dc.authorsophos	Aranda, E.
dc.authorsophos	Garcia-Alfonso, P.
dc.authorsophos	Benavides, M.
dc.authorsophos	Sanchez-Ruiz, A.
dc.authorsophos	Guillen-Ponce, C.
dc.authorsophos	Safont, M. J.
dc.authorsophos	Alcaide, J.
dc.authorsophos	Gomez, A.
dc.authorsophos	Lopez, R.
dc.authorsophos	Manzano, J. L.
dc.authorsophos	Mendez-Urena, M.
dc.authorsophos	Lopez, C.
dc.authorsophos	Garcia-Paredes, B.
dc.authorsophos	Gravalos, C.
dc.authorsophos	Garcia-Garcia, T.
dc.authorsophos	Falco, E.
dc.authorsophos	Martin-Valades, J. I.
dc.authorsophos	Gonzalez-Flores, E.
dc.authorsophos	Navalon, M.
dc.authorsophos	Diaz-Rubio, E.
dc.identifier.isi	361887401469
dc.identifier.sophos	18885
dc.issue.number	Sup 3
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Oncoloxía médica
dc.page.initial	S371
dc.page.final	S372
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	51

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.